INTERNATIONAL CARDIONCOLOGY SOCIETY OF NORTH AMERICA INC (EIN 272139051) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

Stephen Casselli

Phone

8133235448

Tax Period

2025-01-01 to 2025-12-31

INTERNATIONAL CARDIONCOLOGY SOCIETY OF NORTH AMERICA INC, founded in 2010, is a small nonprofit in the Philanthropy & Grantmaking sector that reported $653K in total revenue in fiscal year 2025. Revenue surged 89% from the prior year, signaling strong growth momentum. The organization ran a surplus of $124K, a strong 19% operating margin.

Mission

Mission: We exist to advance cardiovascular care of cancer patients and survivors by promoting collaboration among researchers, educators, and clinicians around the world. We arrange international conferences of doctors, educators, and medical researchers in the field of cardio-oncology. We publish and produce journals of peer-reviewed articles and weekly educational webinars for continuing medical education (CME).

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $541,412

Program Service Revenue $91,488

Investment Income $7,782

Other Revenue $12,752

TOTAL REVENUE $653,434

Expense Breakdown

Grants Paid $0

Salaries & Benefits $188,230

Fundraising Expenses $0

Program Expenses $246,359

Other Expenses $341,015

TOTAL EXPENSES $529,245

Year-over-Year Comparison

	2025	2024	Change
Revenue	$653,434	$345,486	+0.9%
Expenses	$529,245	$346,583	+0.5%
Net Income	$124,189	$-1,097	-114.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$153,284

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Stephen J Casselli	Executive Director	50	Key Emp Highest	$137,500	$0	$137,500
Kathryn L Brannan	Executive Assistant	15	Key Emp	$15,784	$0	$15,784

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$653,434	$529,245	$583,277	$124,189
2024	No data	No data	No data	No data
2023	$490,309	$442,693	$335,910	$47,616
2022	$514,041	$507,734	$324,266	$6,307
2021	$410,238	$260,772	$262,186	$149,466

INTERNATIONAL CARDIONCOLOGY SOCIETY OF NORTH AMERICA INC